Skip to main content
SpringerLink
Log in

Metastatic Ovarian Tumors (Clinical Setting and US)

  • Chapter
  • First Online:
Ovarian Neoplasm Imaging

Abstract

Ovarian neoplasms of metastatic origin account for up to 20 % of all cases of ovarian malignant tumors and present a special challenge to accurate diagnosis with regard to their nature and origin. This chapter outlines the basic guidelines for a multifaceted approach to their diagnosis and summarizes extensive ultrasound observation into general principles that are helpful in correctly assessing the metastatic nature of these tumors as well as in finding the possible primary site. Using these combined methods, the diagnostic accuracy could reach 90 %.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Young RH, Scully RE. Metastatic tumors in the ovary: a problem-oriented approach and review of the recent literature. Semin Diagn Pathol. 1991;8:250–76.

    CAS  PubMed  Google Scholar 

  2. Fischerova D, Cibula D, Dundr P, et al. Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors. Int J Gynecol Cancer. 2008;18:833–7.

    Article  CAS  PubMed  Google Scholar 

  3. Zikan M, Fischerova D, Pinkavova I, et al. Ultrasound-guided tru-cut biopsy of abdominal and pelvic tumors in gynecology. Ultrasound Obstet Gynecol. 2010;36:767–72.

    Article  CAS  PubMed  Google Scholar 

  4. Fischerova D. Ultrasound scanning of the pelvis and abdomen for staging of gynecological tumors: a review. Ultrasound Obstet Gynecol. 2011;38:246–66.

    Article  CAS  PubMed  Google Scholar 

  5. Timmerman D, Valentin L, Bourne TH, et al. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol. 2000;16:500–5.

    Article  CAS  PubMed  Google Scholar 

  6. Guerriero S, Alcazar JL, Pascual MA, et al. Preoperative diagnosis of metastatic ovarian cancer is related to origin of primary tumor. Ultrasound Obstet Gynecol. 2012;39:581–6.

    Article  CAS  PubMed  Google Scholar 

  7. Testa AC, Mancari R, Di Legge A, et al. The ‘lead vessel’: a vascular ultrasound feature of metastasis in the ovaries. Ultrasound Obstet Gynecol. 2008;31:218–21.

    Article  CAS  PubMed  Google Scholar 

  8. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24:5313–27.

    Article  CAS  PubMed  Google Scholar 

  9. Malaguarnera G, Giordano M, Paladina I, et al. Markers of bile duct tumors. World J Gastrointest Oncol. 2011;3:49–59.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Steinberg W. The clinical utility of the CA 19–9 tumor-associated antigen. Am J Gastroenterol. 1990;85:350–5.

    CAS  PubMed  Google Scholar 

  11. Guadagni F, Roselli M, Cosimelli M, et al. CA 72–4 serum marker – a new tool in the management of carcinoma patients. Cancer Invest. 1995;13:227–38.

    Article  CAS  PubMed  Google Scholar 

  12. Keshaviah A, Dellapasqua S, Rotmensz N, et al. CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: a combined analysis of seven International Breast Cancer Study Group trials. Ann Oncol. 2007;18:701–8.

    Article  CAS  PubMed  Google Scholar 

  13. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol. 2007;25:5287–312.

    Article  CAS  PubMed  Google Scholar 

  14. Laboratory Medicine Practice Guidelines. 2010. Use of tumor markers in liver, bladder, cervical, and gastric cancers. www.aacc.org

  15. Chaube A, Tewari M, Singh U, et al. CA 125: a potential tumor marker for gallbladder cancer. J Surg Oncol. 2006;93:665–9.

    Article  CAS  PubMed  Google Scholar 

  16. Van Calster B, Valentin L, Van Holsbeke C, et al. A novel approach to predict the likelihood of specific ovarian tumor pathology based on serum CA-125: a multicenter observational study. Cancer Epidemiol Biomarkers Prev. 2011;20:2420–8.

    Article  PubMed  Google Scholar 

  17. Scully RE, Richardson GS. Luteinization of the stroma of metastatic cancer involving the ovary and its endocrine significance. Cancer. 1961;14:827–40.

    Article  CAS  PubMed  Google Scholar 

  18. Testa AC, Ferrandina G, Timmerman D, et al. Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor. Ultrasound Obstet Gynecol. 2007;29:505–11.

    Article  CAS  PubMed  Google Scholar 

  19. Valentin L, Ameye L, Testa A, et al. Ultrasound characteristics of different types of adnexal malignancies. Gynecol Oncol. 2006;102:41–8.

    Article  PubMed  Google Scholar 

  20. Alcazar JL, Galan MJ, Ceamanos C, et al. Transvaginal gray scale and color Doppler sonography in primary ovarian cancer and metastatic tumors to the ovary. J Ultrasound Med. 2003;22:243–7.

    PubMed  Google Scholar 

  21. Zikan M, Fischerova D, Pinkavova I, et al. Ultrasonographic appearance of metastatic non-gynecological pelvic tumors. Ultrasound Obstet Gynecol. 2012;39:215–25.

    Article  CAS  PubMed  Google Scholar 

  22. Prat J, Morice P. Secondary tumours of the ovary. In: Tavassoli FA, Devilee P, editors. Pathology and genetics of tumours of the breast and female genital organs. Lyon: IARC Press; 2003.

    Google Scholar 

  23. Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incidence in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol. 2003;27:985–93.

    Article  PubMed  Google Scholar 

  24. Yemelyanova AV, Vang R, Judson K, et al. Distinction of primary and metastatic mucinous tumors involving the ovary: analysis of size and laterality data by primary site with reevaluation of an algorithm for tumor classification. Am J Surg Pathol. 2008;32:128–38.

    Article  PubMed  Google Scholar 

  25. Lerwill MF, Young RH. Metastatic tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s pathology of the female genital tract. 6th ed. New York: Springer Science + Business Medica; 2011. p. 929–97.

    Chapter  Google Scholar 

  26. Tso PL, Bringaze WL, Dauterive AH, et al. Gastric carcinoma in the young. Cancer. 1987;59:1362–5.

    Article  CAS  PubMed  Google Scholar 

  27. Hale RW. Krukenberg tumor of the ovaries. A review of 81 records. Obstet Gynecol. 1968;32:221–5.

    CAS  PubMed  Google Scholar 

  28. Demopoulos RI, Touger L, Dubin N. Secondary ovarian carcinoma: a clinical and pathological evaluation. Int J Gynecol Pathol. 1987;6:166–75.

    Article  CAS  PubMed  Google Scholar 

  29. Savey L, Lasser P, Castaigne D, et al. Krukenberg tumors. Analysis of a series of 28 cases. J Chir (Paris). 1996;133:427–31.

    CAS  Google Scholar 

  30. Paladini D, Testa A, Van Holsbeke C, et al. Imaging in gynecological disease (5): clinical and ultrasound characteristics in fibroma and fibrothecoma of the ovary. Ultrasound Obstet Gynecol. 2009;34:188–95.

    Article  CAS  PubMed  Google Scholar 

  31. Guerriero S, Testa AC, Timmerman D, et al. Imaging of gynecological disease (6): clinical and ultrasound characteristics of ovarian dysgerminoma. Ultrasound Obstet Gynecol. 2011;37:596–602.

    Article  CAS  PubMed  Google Scholar 

  32. Birnkrant A, Sampson J, Sugarbaker PH. Ovarian metastasis from colorectal cancer. Dis Colon Rectum. 1986;29:767–71.

    Article  CAS  PubMed  Google Scholar 

  33. Graffner HO, Alm PO, Oscarson JE. Prophylactic oophorectomy in colorectal carcinoma. Am J Surg. 1983;146:233–5.

    Article  CAS  PubMed  Google Scholar 

  34. Judson K, McCormick C, Vang R, et al. Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement. Int J Gynecol Pathol. 2008;27:182–90.

    PubMed  Google Scholar 

  35. Colon cancer. In: National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology (NCCN Guidelines). Version 3.2012. www.nccn.org

  36. Lash RH, Hart WR. Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases. Am J Surg Pathol. 1987;11:114–21.

    Article  CAS  PubMed  Google Scholar 

  37. Ulbright TM, Goheen MP, Roth LM, et al. The differentia-tion of carcinomas of teratomatous origin from embryonal carcinoma. A light and electron microscopic study. Cancer. 1986;57:257–63.

    Article  CAS  PubMed  Google Scholar 

  38. Ronnett BM, Kajdacsy-Balla A, Gilks CB, et al. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol. 2004;35:949–60.

    Article  PubMed  Google Scholar 

  39. McKenney JK, Soslow RA, Longacre TA. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei. Am J Surg Pathol. 2008;32:645–55.

    Article  PubMed  Google Scholar 

  40. Ronnett BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas: relationship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol. 2003;27:650–7.

    Article  PubMed  Google Scholar 

  41. van Ruth S, Hart AA, Bonfrer JM, et al. Prognostic value of baseline and serial carcinoembryonic antigen and carbohydrate antigen 19.9 measurements in patients with pseudomyxoma peritonei treated with cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2002;9:961–7.

    Article  PubMed  Google Scholar 

  42. Fruscella E, Testa AC, Ferrandina G, et al. Ultrasound features of different histopathological subtypes of borderline ovarian tumors. Ultrasound Obstet Gynecol. 2005;26:644–50.

    Article  CAS  PubMed  Google Scholar 

  43. Robboy SJ, Scully RE, Norris HJ. Carcinoid metastatic to the ovary. A clinicopathologic analysis of 35 cases. Cancer. 1974;33:798–811.

    Article  CAS  PubMed  Google Scholar 

  44. Strosberg J, Nasir A, Cragun J, et al. Metastatic carcinoid tumor to the ovary: a clinicopathologic analysis of seventeen cases. Gynecol Oncol. 2007;106:65–8.

    Article  PubMed  Google Scholar 

  45. Ulbright TM, Roth LM, Stehman FB. Secondary ovarian neoplasia. A clinicopathologic study of 35 cases. Cancer. 1984;53:1164–74.

    Article  CAS  PubMed  Google Scholar 

  46. Brown BL, Scharifker DA, Gordon R, et al. Bronchial carcinoid tumor with ovarian metastasis: a light microscopic and ultrastructural study. Cancer. 1980;46:543–6.

    Article  CAS  PubMed  Google Scholar 

  47. Riopel MA, Ronnett BM, Kurman RJ. Evaluation of diagnostic criteria and behavior of ovarian intestinal-type mucinous tumors: atypical proliferative (borderline) tumors and intraepithelial, microinvasive, invasive, and metastatic carcinomas. Am J Surg Pathol. 1999;23:617–35.

    Article  CAS  PubMed  Google Scholar 

  48. Seidman JD, Soslow RA, Vang R, et al. Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images. Hum Pathol. 2004;35:918–33.

    Article  PubMed  Google Scholar 

  49. Young RH, Scully RE. Differential diagnosis of ovarian tumors based primarily on their patterns and cell types. Semin Diagn Pathol. 2001;18:161–235.

    CAS  PubMed  Google Scholar 

  50. Khunamornpong S, Lerwill MF, Siriaunkgul S, et al. Carcinoma of extrahepatic bile ducts and gallbladder metastatic to the ovary: a report of 16 cases. Int J Gynecol Pathol. 2008;27:366–79.

    Article  PubMed  Google Scholar 

  51. Khan SA, Davidson BR, Goldin R, et al. Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut. 2002;51 Suppl 6:VI1–9.

    PubMed  Google Scholar 

  52. Gagnon Y, Tetu B. Ovarian metastases of breast carcinoma. A clinicopathologic study of 59 cases. Cancer. 1989;64:892–8.

    Article  CAS  PubMed  Google Scholar 

  53. Young RH, Carey RW, Robboy SJ. Breast carcinoma masquerading as primary ovarian neoplasm. Cancer. 1981;48:210–2.

    Article  CAS  PubMed  Google Scholar 

  54. Harris M, Howell A, Chrissohou M, et al. A comparison of the metastatic pattern of infiltrating lobular carcinoma and infiltrating duct carcinoma of the breast. Br J Cancer. 1984;50:23–30.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Seidman JD, Cho KR, Ronnett BM, et al. Surface epithelial tumors of the ovary. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s pathology of the female genital tract. 6th ed. New York: Springer Science + Business Medica; 2011.

    Google Scholar 

  56. Van Holsbeke C, Domali E, Holland TK, et al. Imaging of gynecological disease (3): clinical and ultrasound characteristics of granulosa cell tumors of the ovary. Ultrasound Obstet Gynecol. 2008;31:450–6.

    Article  PubMed  Google Scholar 

  57. Ferry JA. Hematologic neoplasm and selected tumor-like lesions involving the female reproductive organs. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s pathology of the female genital tract. 6th ed. New York: Springer Science + Business Medica; 2011.

    Google Scholar 

  58. Barcos M, Lane W, Gomez GA, et al. An autopsy study of 1206 acute and chronic leukemias (1958 to 1982). Cancer. 1987;60:827–37.

    Article  CAS  PubMed  Google Scholar 

  59. Kurman RJ, Shih Ie M. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory. Am J Surg Pathol. 2010;34:433–43.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Takeshima N, Hirai Y, Yano K, et al. Ovarian metastasis in endometrial carcinoma. Gynecol Oncol. 1998;70:183–7.

    Article  CAS  PubMed  Google Scholar 

  61. Epstein E, Van Holsbeke C, Mascilini F, et al. Gray-scale and color Doppler ultrasound characteristics of endometrial cancer in relation to stage, grade and tumor size. Ultrasound Obstet Gynecol. 2011;38:586–93.

    Article  CAS  PubMed  Google Scholar 

  62. Ulbright TM, Roth LM. Metastatic and independent cancers of the endometrium and ovary: a clinicopathologic study of 34 cases. Hum Pathol. 1985;16:28–34.

    Article  CAS  PubMed  Google Scholar 

  63. Prat J, Matias-Guiu X, Barreto J. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immunohistochemical, and DNA flow cytometric study of 18 cases. Cancer. 1991;68:2455–9.

    Article  CAS  PubMed  Google Scholar 

  64. Halperin R, Zehavi S, Hadas E, et al. Simultaneous carcinoma of the endometrium and ovary vs endometrial carcinoma with ovarian metastases: a clinical and immunohistochemical determination. Int J Gynecol Cancer. 2003;13:32–7.

    Article  CAS  PubMed  Google Scholar 

  65. Tabata M, Ichinoe K, Sakuragi N, et al. Incidence of ovarian metastasis in patients with cancer of the uterine cervix. Gynecol Oncol. 1987;28:255–61.

    Article  CAS  PubMed  Google Scholar 

  66. Young RH, Gersell DJ, Roth LM, et al. Ovarian metastases from cervical carcinomas other than pure adenocarcinomas. A report of 12 cases. Cancer. 1993;71:407–18.

    Article  CAS  PubMed  Google Scholar 

  67. Bloss JD, Liao SY, Buller RE, et al. Extraovarian peritoneal serous papillary carcinoma: a case–control retrospective comparison to papillary adenocarcinoma of the ovary. Gynecol Oncol. 1993;50:347–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgement

Thanks to Adam Preisler from the Faculty of Architecture, Czech Technical University in Prague for providing the illustrations. This work was supported by the Internal Grant Agency of the Ministry of Health, the Czech Republic (grant NT13070), and by Charles University in Prague (UNCE 204024 and PRVOUK-P27/LF1/1).

Author information

Authors and Affiliations

  1. Division of Gynecological Oncology Centre, Department of Obstetrics and Gynecology, First Faculty of Medicine and General University Hospital, Charles University in Prague, Apolinarska 18, 120 00, Prague, Czech Republic

    Daniela Fischerova MD, PhD

Authors
  1. Daniela Fischerova MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniela Fischerova MD, PhD .

Editor information

Editors and Affiliations

  1. University of Cagliari, Cagliari, Italy

    Luca Saba

  2. Ngee Ann Polytechnic, Singapore, Singapore

    U. Rajendra Acharya

  3. University of Cagliari, Cagliari, Italy

    Stefano Guerriero

  4. Biomedical Technologies, Inc, Roseville, California, USA

    Jasjit S. Suri

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this chapter

Cite this chapter

Fischerova, D. (2013). Metastatic Ovarian Tumors (Clinical Setting and US). In: Saba, L., Acharya, U., Guerriero, S., Suri, J. (eds) Ovarian Neoplasm Imaging. Springer, Boston, MA. https://doi.org/10.1007/978-1-4614-8633-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-8633-6_22

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4614-8632-9

  • Online ISBN: 978-1-4614-8633-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation